RIO DE JANEIRO, BRAZIL – Only 1 per cent of Argentinian citizens, who received the Russia-developed Sputnik V vaccine against the coronavirus, has shown a mild adverse reaction to the shot, the TN broadcaster reported on Saturday, January 2nd, citing the country’s Health Ministry.
According to the media outlet, 317 patients out of 32,013, reported fever and headaches.
Argentina started its mass vaccination campaign with the Russian Sputnik V vaccine on Tuesday. Earlier in December, it received the first batch of 300,000 doses of the jab.
Health workers are the first to get shots of the vaccine.
The Sputnik V was the first COVID-19 vaccine registered in Russia and the world. Russia’s Sputnik V claims to be 92 percent effective, based on data from the first 16,000 trial participants who have received both shots of the two-dose vaccine.